Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Shields

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2020
Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal CancerJim P Abraham, Daniel Magee, Chiara Cremolini, et al.
JAMA|April 6, 2021
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical TrialJeffrey A Meyerhardt, Qian Shi, Charles S Fuchs, et al.
The New England Journal of Medicine|March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon CancerAxel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)Alberto Puccini, Kelsey Poorman, Mohamed E Salem, et al.
International Journal of Cancer|December 31, 2024
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomesPooja Mittal, Francesca Battaglin, Yasmine Baca, et al.
NPJ Precision Oncology|October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patientsAlberto Puccini, Andreas Seeber, Joanne Xiu, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world dataKaram Ashouri, Joshua Millstein, Yan Yang, et al.
ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
Molecular Cancer Therapeutics|September 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung CancersHusain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2025
Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patientsDaniel Magee, Valeriy Domenyuk, Jim Abraham, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2020
Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal CancerJim P Abraham, Daniel Magee, Chiara Cremolini, et al.
JAMA|April 6, 2021
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical TrialJeffrey A Meyerhardt, Qian Shi, Charles S Fuchs, et al.
The New England Journal of Medicine|March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon CancerAxel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)Alberto Puccini, Kelsey Poorman, Mohamed E Salem, et al.
International Journal of Cancer|December 31, 2024
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomesPooja Mittal, Francesca Battaglin, Yasmine Baca, et al.
NPJ Precision Oncology|October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patientsAlberto Puccini, Andreas Seeber, Joanne Xiu, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Clinical and molecular characterization of <i>AXL</i> in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world dataKaram Ashouri, Joshua Millstein, Yan Yang, et al.
ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
Molecular Cancer Therapeutics|September 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung CancersHusain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2025
Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patientsDaniel Magee, Valeriy Domenyuk, Jim Abraham, et al.
Pageof 19